FDA Inspection
VitalantVitalant – FDA Inspection, Aug 9, 2023
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on August 9, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c66b5bca-9e2f-4761-9095-f71cc97c5588
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1214538
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 18, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 22, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 4, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1098166 - 2019-07-18
- FDA Inspection 984109 - 2016-08-18
- FDA Inspection 895712 - 2014-09-12
- FDA Inspection 789482 - 2012-06-22
- FDA Inspection 604009 - 2009-08-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.